ASGR1: A Potential Drug Target and Biomarker (G432)

Target Name: ASGR1

NCBI ID: G432

ASGR1

ASGR1: A Potential Drug Target and Biomarker

ASGR1 (ASGPR1), also known as ALDH1 gene 10a, is a gene that encodes a protein known as ASGR1. ASGR1 is a member of the Aryl hydrocarbon receptor gene family, which is a family of nuclear receptors that play a critical role in the regulation of cellular processes such as inflammation, metabolism, and signaling pathways.

ASGR1 is expressed in various tissues and cells throughout the body, including the lungs, heart, kidneys, and intestines. It has been shown to be involved in the regulation of cellular processes that are important for human health, including inflammation, fibrosis, and cancer.

Due to its involvement in these processes, ASGR1 has been identified as a potential drug target. Researchers are exploring the use of drugs that can modulate ASGR1 activity to treat a variety of diseases, including cancer, autoimmune diseases, and respiratory disorders.

One approach to targeting ASGR1 is through the use of small molecules, such as inhibitors or modulators, that can modulate the activity of the ASGR1 receptor. These small molecules can be developed and tested in cell culture models or animal models of disease to determine their effectiveness in treating corresponding diseases.

Another approach to targeting ASGR1 is through the use of antibodies that recognize and target specific regions of the ASGR1 protein. These antibodies can be used to treat diseases where ASGR1 is over-expressed or mutated, such as cancer.

In addition to its potential as a drug target, ASGR1 has also been identified as a potential biomarker for a variety of diseases. The ASGR1 gene is expressed in many different tissues and cells throughout the body, which makes it a potential target for diagnostic tests.

Research has shown that ASGR1 is often expressed in tissues that are affected by diseases, such as cancer, fibrosis, and respiratory disorders. By analyzing the expression of ASGR1 in these tissues, researchers can gain insights into the underlying mechanisms of these diseases and identify potential targets for treatment.

In conclusion, ASGR1 is a protein that is involved in a variety of cellular processes that are important for human health. As a potential drug target and biomarker, ASGR1 is a promising target for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of ASGR1 in disease and to develop safe and effective treatments.

Protein Name: Asialoglycoprotein Receptor 1

Functions: Mediates the endocytosis of plasma glycoproteins to which the terminal sialic acid residue on their complex carbohydrate moieties has been removed. The receptor recognizes terminal galactose and N-acetylgalactosamine units. After ligand binding to the receptor, the resulting complex is internalized and transported to a sorting organelle, where receptor and ligand are disassociated. The receptor then returns to the cell membrane surface

The "ASGR1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ASGR1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets